Huagai Capital Overview
- Investor Type
-
Venture Capital
- Investments
-
273
- Portfolio
-
173
- Exits
-
62
Huagai Capital General Information
Company Description
Founded in 2012, Huagai Capital is a Venture Capital and Private Equity firm headquartered in Beijing, China. The firm seeks to invest in companies operating within the healthcare, tmt and cultural industries.
Business Details
Website
www.huagaicapital.comPrimary Investor Type
Other Investor Types
Corporate Office
- 505-508, 5th Floor, China Resources Building
- No. 8 Jianguomen North Street, Dongcheng District
- Beijing
- China
Huagai Capital Investments (273)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Eli (Drug Discovery) | 11-Nov-2026 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Allygen Biosciences | 13-Oct-2026 | Drug Discovery | Generating Revenue | |||
| Hyperway (Drug Discovery) | 30-Sep-2026 | Drug Discovery | Generating Revenue | |||
| BCIFlex | 21-Sep-2026 | Therapeutic Devices | Generating Revenue | |||
| Wuxi Latticon | 16-Sep-2026 | Drug Discovery | Generating Revenue | |||
| Ray Everest | 23-Jun-2026 | Discovery Tools (Healthcare) | Generating Revenue | |||
| WingSemi Technology | 20-May-2026 | Computers, Parts and Peripherals | Generating Revenue | |||
| TanWei Chiplink | 12-May-2026 | Application Specific Semiconductors | Generating Revenue | |||
| SenseTime Medical | 20-Apr-2026 | Early Stage VC | Business/Productivity Software | Generating Revenue | ||
| Haihe Biopharma | 01-Mar-2026 | Secondary Transaction - Private | Drug Discovery | Clinical Trials - General |
Huagai Capital Exits (62)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Alebund Pharmaceuticals | 29-Jun-2026 | IPO | |
| Beijing Zhongke WengeAI Science and Technology | 26-Jun-2026 | ||
| Galaxis Technology | 24-Mar-2026 | ||
| Newrank | 11-Feb-2026 | ||
| Insight Lifetech | 05-Feb-2026 | ||
| SinoVision Technology | 22-Dec-2025 | ||
| SinoVision Technology | 09-Oct-2025 | ||
| Genfleet | 19-Sep-2025 | ||
| Geneplus Technology | 31-Jul-2025 | Secondary Transaction - Private | |
| Commchina | 09-Jul-2025 | IPO |
Huagai Capital Investments by Industry, Year, and Region
Huagai Capital Co-Investors (188)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| TigerYeah Capital | 4 |
|
|
||
| YuanBio Venture Capital |
|
|
|||
| Legend Capital |
|
|
|||
| Shanghai Wenzhou Capital |
|
|
|||
| Qiming Venture Partners |
|
|
Huagai Capital FAQs
-
What is Huagai Capital?
Founded in 2012, Huagai Capital is a Venture Capital and Private Equity firm headquartered in Beijing, China.
-
Where is Huagai Capital headquartered?
Huagai Capital is headquartered in Beijing, China.
-
What is Huagai Capital's total asset value?
Huagai Capital has around in total assets under management.
-
How many investments has Huagai Capital made?
Huagai Capital has made 273 investments.
-
What has Huagai Capital invested in?
Huagai Capital has made numerous investments in companies like Eli (Drug Discovery), Allygen Biosciences, and Hyperway (Drug Discovery) within the Drug Discovery industry.
-
What has Huagai Capital invested in recently?
Huagai Capital's latest investment was on 11-Nov-2026 in Eli (Drug Discovery), a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process